84196-28-1(Cuprate(5-), [μ-[2-[[1-[4-[2-[4-[[4-[[4-[2-[4-[4-[(2-carboxyphenyl)azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]-2-sulfophenyl]ethenyl]-3-sulfophenyl]amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]-3-sulfophenyl]-4,5-dihydro-3-)

84196-28-1 Basic information More..

Product Name:	Cuprate(5-), [μ-[2-[[1-[4-[2-[4-[[4-[[4-[2-[4-[4-[(2-carboxyphenyl)azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]-2-sulfophenyl]ethenyl]-3-sulfophenyl]amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]-3-sulfophenyl]-4,5-dihydro-3-
Synonyms:	5-dihydro-3-methyl-5-oxo-1h-pyrazol-4-yl]azo]-5-sulfobenzoato(9-)]]di-enyl]-;Cuprate(5-), [μ-[2-[[1-[4-[2-[4-[[4-[[4-[2-[4-[4-[(2-carboxyphenyl)azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]-2-sulfophenyl]ethenyl]-3-sulfophenyl]amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]-3-sulfophenyl]-4,5-dihydro-3-;Cuprate(5-),[μ-[2-[[1-[4-[2-[4-[[4-[[4-[2-[4-[4-[(2-carboxyphenyl)azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]-2-sulfophenyl]ethenyl]-3-sulfophenyl]amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]-3-sulfophenyl]-4,5-dihyd;ino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]-3-sulfoph
CAS:	84196-28-1
MF:	C59H37Cu2N14NaO21S5(-4)
MW:	1588.41
EINECS:
Mol File:	Mol File

Information Error Report

Your Email:

Browse by Nationality 84196-28-1 Suppliers

84196-28-1 Recommend Suppliers

Recommend You Select Member Companies.

Tag: 84196-28-1

HomePage | About Us | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms
All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.